Subject: State Agency Leaders Featured Resource: FAQs Regarding Part 2 and Prescription Drug Monitoring Programs (PDMPs)

CAI


State Agency Leaders

Monthly Featured Resource #2

FAQs Regarding Part 2 and

Prescription Drug Monitoring Programs (PDMPs)

How to use this information:

As a State Agency Leader, your behavioral health provider network looks to you for simple, actionable tools to interpret and apply privacy regulations on the job.


The CoE-PHI website houses resources to help you play this role and will be featuring key resources that you can share with your colleagues and provider networks over the next several months.

This month's featured resource:

Who is this for?

People working within organizations that provide substance use treatment services, and Prescription Drug Monitoring Program Administrators.

What is this about?

As an organizational leader or provider of substance use treatment services, it is important to keep track of prescriptions provided to your clients- especially opioids. To do that, information about prescriptions for opioids are entered into individual state Prescription Drug Monitoring Program (PDMP) databases.


This includes patient-level information, and organizations and providers often have questions about how protections provided by 42 CFR Part 2 might apply to the information they are required to share with PDMPs.

Key Points:

  • PDMPs that receive Part 2 records must protect the privacy and security of the records, including from law enforcement.

  • Substance use treatment programs are permitted to report Part 2-protected information (e.g., medications dispensed for substance use treatment) to their individual state PDMPs, but only if required by state law, and if the patient consents in writing to sharing that information with the PDMP.

View Resource Now

Make sure your provider network has the information they need.

We encourage you to send this communication on to your colleagues and network of providers to make sure they have the information they need to coordinate care and protect patient privacy.

For any questions or concerns, or to share a resource or request technical assistance, please contact us on our website.


Join our mailing list to be notified when the CoE-PHI releases new learning opportunities and resources, or our dedicated Privacy, Compliance, and Quality (PCQ) mailing list for access to complete training packages that can be used by organizations.

Funded by SAMHSA, the CoE-PHI develops and disseminates resources, training, and TA for states, healthcare providers, school administrators and individuals and families to improve understanding and application of federal privacy laws and regulations, including FERPA, HIPAA, and 42 CFR Part 2, when providing and receiving treatment for SUD and mental illness.


Resources, training, technical assistance, and any other information provided through the CoE-PHI do not constitute legal advice.

CAI, 505 Eighth Avenue 1900, New York, NY 10018, United States

You may unsubscribe or change your contact details at any time.

    This is an online snapshot of a newsletter created by the owner of coe_for_protectedhealthinformation (CAI, 505 Eighth Avenue 1900, 10018 New York, United States) and sent via GetResponse on 2024-10-17. Report abuse